Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 35% ± 5% | |
hepatocyte | 3 studies | 29% ± 8% |
Insufficient scRNA-seq data for expression of SLC15A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 736.15 | 327 / 328 | 90% | 14.46 | 161 / 178 |
liver | 99% | 1396.89 | 224 / 226 | 83% | 18.57 | 337 / 406 |
kidney | 85% | 786.28 | 76 / 89 | 53% | 9.11 | 474 / 901 |
esophagus | 18% | 72.00 | 260 / 1445 | 66% | 7.31 | 121 / 183 |
skin | 72% | 2095.32 | 1297 / 1809 | 6% | 0.88 | 30 / 472 |
intestine | 34% | 2430.98 | 327 / 966 | 41% | 4.04 | 216 / 527 |
prostate | 38% | 196.17 | 94 / 245 | 31% | 1.87 | 157 / 502 |
uterus | 20% | 99.88 | 34 / 170 | 46% | 5.30 | 212 / 459 |
bladder | 0% | 0 | 0 / 21 | 57% | 8.41 | 288 / 504 |
stomach | 5% | 14.51 | 17 / 359 | 47% | 4.71 | 135 / 286 |
lung | 0% | 0 | 0 / 578 | 41% | 3.64 | 478 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 27% | 1.43 | 12 / 45 |
ovary | 0% | 0 | 0 / 180 | 19% | 1.07 | 81 / 430 |
thymus | 3% | 11.81 | 17 / 653 | 14% | 0.88 | 86 / 605 |
breast | 1% | 2.76 | 3 / 459 | 13% | 2.16 | 148 / 1118 |
adipose | 0% | 3.33 | 6 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.06 | 1 / 230 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.02 | 3 / 705 |
spleen | 0% | 1.47 | 1 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.51 | 1 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.89 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006811 | Biological process | monoatomic ion transport |
GO_0015031 | Biological process | protein transport |
GO_0140206 | Biological process | dipeptide import across plasma membrane |
GO_0015833 | Biological process | peptide transport |
GO_0140207 | Biological process | tripeptide import across plasma membrane |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0005903 | Cellular component | brush border |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0042937 | Molecular function | tripeptide transmembrane transporter activity |
GO_0071916 | Molecular function | dipeptide transmembrane transporter activity |
GO_0005427 | Molecular function | proton-dependent oligopeptide secondary active transmembrane transporter activity |
GO_0015333 | Molecular function | peptide:proton symporter activity |
Gene name | SLC15A1 |
Protein name | Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1) |
Synonyms | PEPT1 |
Description | FUNCTION: Electrogenic proton-coupled amino-acid transporter that transports oligopeptides of 2 to 4 amino acids with a preference for dipeptides. Transports neutral and monovalently charged peptides with a proton to peptide stoichiometry of 1:1 or 2:1 (By similarity). Primarily responsible for the absorption of dietary di- and tripeptides from the small intestinal lumen (By similarity). Mediates transepithelial transport of muramyl and N-formylated bacterial dipeptides contributing to recognition of pathogenic bacteria by the mucosal immune system . . |
Accessions | ENST00000376503.10 Q4VAL9 P46059 |